|
|
Line 3: |
Line 3: |
| <StructureSection load='4l0u' size='340' side='right'caption='[[4l0u]], [[Resolution|resolution]] 2.50Å' scene=''> | | <StructureSection load='4l0u' size='340' side='right'caption='[[4l0u]], [[Resolution|resolution]] 2.50Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[4l0u]] is a 10 chain structure with sequence from [http://en.wikipedia.org/wiki/Plavs Plavs]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L0U OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4L0U FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4l0u]] is a 10 chain structure with sequence from [https://en.wikipedia.org/wiki/Plasmodium_vivax_Sal-1 Plasmodium vivax Sal-1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L0U OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4L0U FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene></td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2h66|2h66]], [[4l0w|4l0w]]</td></tr>
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4l0u FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l0u OCA], [https://pdbe.org/4l0u PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4l0u RCSB], [https://www.ebi.ac.uk/pdbsum/4l0u PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4l0u ProSAT]</span></td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PVX_118545 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=126793 PLAVS])</td></tr>
| + | |
- | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Peroxiredoxin Peroxiredoxin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.11.1.15 1.11.1.15] </span></td></tr>
| + | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l0u FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l0u OCA], [http://pdbe.org/4l0u PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4l0u RCSB], [http://www.ebi.ac.uk/pdbsum/4l0u PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4l0u ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/A5K421_PLAVS A5K421_PLAVS] |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 24: |
Line 23: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Peroxiredoxin]] | + | [[Category: Plasmodium vivax Sal-1]] |
- | [[Category: Plavs]]
| + | [[Category: Gretes MC]] |
- | [[Category: Gretes, M C]] | + | [[Category: Karplus PA]] |
- | [[Category: Karplus, P A]] | + | |
- | [[Category: Antioxidant]]
| + | |
- | [[Category: Disulfide]]
| + | |
- | [[Category: Malaria parasite]]
| + | |
- | [[Category: Oxidoreductase]]
| + | |
| Structural highlights
Function
A5K421_PLAVS
Publication Abstract from PubMed
Peroxiredoxins (Prxs) are ubiquitous and efficient antioxidant enzymes crucial for redox homeostasis in most organisms, and are of special importance for disease-causing parasites that must protect themselves against the oxidative weapons of the human immune system. Here, we describe reanalyses of crystal structures of two Prxs from malaria parasites. In addition to producing improved structures, we provide normalizing explanations for features that had been noted as unusual in the original report of these structures (Qiu et al., BMC Struct Biol 2012;12:2). Most importantly, we provide evidence that the unusual octameric assembly seen for Plasmodium yoelii Prx1a is not physiologically relevant, but arises because the structure is not of authentic P. yoelii Prx1a, but a variant we designate PyPrx1a(N*) that has seven native N-terminal residues replaced by an affinity tag. This N-terminal modification disrupts a previously unrecognized, hydrophobic "ball-and-socket" interaction conserved at the B-type dimer interface of Prx1 subfamily enzymes, and is accommodated by a fascinating two-residue "beta-slip" type register shift in the beta-strand association at a dimer interface. The resulting change in the geometry of the dimer provides a simple explanation for octamer formation. This study illustrates how substantive impacts can occur in protein variants in which native residues have been altered.
Observed octameric assembly of a Plasmodium yoelii peroxiredoxin can be explained by the replacement of native "ball-and-socket" interacting residues by an affinity tag.,Gretes MC, Karplus PA Protein Sci. 2013 Oct;22(10):1445-52. doi: 10.1002/pro.2328. PMID:23934758[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Gretes MC, Karplus PA. Observed octameric assembly of a Plasmodium yoelii peroxiredoxin can be explained by the replacement of native "ball-and-socket" interacting residues by an affinity tag. Protein Sci. 2013 Oct;22(10):1445-52. doi: 10.1002/pro.2328. PMID:23934758 doi:http://dx.doi.org/10.1002/pro.2328
|